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Then said they unto him, Say now Shibboleth: and he said
Sibboleth: for he could not frame to pronounce it right. Then they took
him and slew him, at the passes of Jordan: and there fell at that time
of the Ephraimites forty and two thousand.
Judges 12:6
I
n Old Testament times, mispronunciation bore a price. The
Gileadites (circa 1143 B.C.) used pronunciation to differenti-
ate their own from the Ephraimites, and the consequences of
mispronunciation were severe. Today, mispronunciation,
though not a matter of life and death, presents problems when
it interferes with communication. In scientific nomenclature,
Greek or Latin bionomials of infectious disease microorgan-
isms are often mispronounced, sometimes causing confusion
among healthcare professionals (e.g., infectious disease physi-
cians, epidemiologists, and even microbiologists). Unlike hor-
ticulturalists, who have masterfully developed a large reper-
toire of common names for botanical species thereby avoiding
the need for and potential mispronunciation of classical Greek
and Latin, infectious disease specialists still rely on Greek and
Latin bionomials. 
How important is a standard pronunciation of bionomials?
Language is about communication. Provided the parties in a
discussion can understand each other, variations in pronuncia-
tion of individual words can be tolerated or disregarded.
Everyday modern English is filled with examples of variant
pronunciations that cause no communication problems (e.g.,
either, tomato, laboratory, fertile). These variant pronunciations
have many causes. Regional practice is probably the single
most important variant, but educational and social backgrounds
also play a part, as do personal preferences and even etymolog-
ic theories. It would be futile and (some believe) undesirable to
impose uniformity by prescribing approved pronunciations
when communication is not compromised. Moreover, in all lan-
guages, pronunciation changes constantly. 
Burkholderia cepacia, an important gram-negative bacteri-
al pathogen in patients with cystic fibrosis, may cause prema-
ture death in these patients. Since its first description in 1950
by Walter Burkholder (1), the pathogen has undergone several
taxonomic reclassifications (2) in accordance with the
Bacteriologic Code (1990 revision). However, uncertainty still
surrounds the clinical relevance of its evolving taxonomy, par-
ticularly in regards to the nine described genomovars of the B.
cepacia complex (BCC). The species name cepa’cia comes
from L. fem. N. caepa or cepa (onion). Most confusion sur-
rounding this species name was initially due to its transfer from
the genus Pseudomonas to the newly described genus
Burkholderia by Yabuuchi et al. in 1992 (3). The practice of
renaming individual BBC genomovars with species names
when phenotypic differentiation becomes available has height-
ened the confusion, as in the renaming of B. cepacia
genomovar II to B. multivorans, where problems arise both
with physicians (in infection control) and with patients (psy-
chological acceptance of the disease). 
Even though in B. cepacia, taxonomic issues rather than
pronunciation are at the root of confusion, the pathogen neatly
encapsulates several aspects of the linguistic conundrum
involving “correct” pronunciation of Latin binomials. The cor-
rect pronunciation of both the genus Burkholderia  and the
species cepacia is still debated. The debate is mainly about the
correct pronunciation of cepacia, but the genus name,
Burkholderia, also deserves some consideration. The genus
name is formed from the surname Burkholder, on which a Latin
suffix –ia has been grafted. How should this synthetic word be
pronounced? With the original pronunciation of the name
retained as far as possible (long o and stress on second syllable)
or with a more Latinized effect (short o and stress on third syl-
lable, possibly lengthening its vowel)? Or is this in fact a non-
existent problem because the word is normally encountered in
print so variations in pronunciation present no confusion?
The scientific and infectious disease communities would
benefit from the adoption of a standard pronunciation of Latin
binomials that would obviate confusion and ambiguities. The
Linnaean binomial system uses Latin morphology and gram-
mar in forming its names, and they are equally respected in
China and Peru. Why not adopt a standard pronunciation? An
immediate practical objection is that there is hardly a “standard
Latin pronunciation.” Throughout history, Latin pronunciation
has developed in accordance to the vernacular language of its
users. Even as long ago as the 16th century, when Latin was of
necessity the common language of such multinational organi-
zations as the Roman Empire and the Catholic Church, speak-
ers of Latin from different nations could not understand each
other. This linguistic situation was satirized in 1528 by
Erasmus, who proposed to standardize a reconstructed version
of classical Latin pronunciation, i.e., the practice (as far as it
could be deduced) of 1,500 years earlier. His efforts had only
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limited success. Two and a half centuries later, Samuel
Johnson, in his Life of Milton, condemned those who, like
Milton, sought to replace the “English” pronunciation with the
“Italian.” A remnant of Johnson’s “English” system still per-
sists in the Latin-derived jargon used by British lawyers.
Toward the end of the 19th century, schoolmasters and classics
scholars began adopting a restored pronunciation (reconstruct-
ed from heterogeneous evidence) that aimed to reproduce Latin
pronunciation in the time of Cicero or Virgil (i.e., the first cen-
turies B.C. and A.D.). This reform was supported in 1923 by a
committee appointed by the Prime Minister of the United
Kingdom, but the “new way” was not universally accepted. 
Analogous situations are found in other European countries.
In Italy, the church pronunciation still carries much prestige. In
France, the reform movement encountered bitter opposition.
However, the views of responsible classics scholars today seem
to converge in both theoretical and practical terms. The most
promising system is described by W. Sidney Allen (4) in which
he uses symbols of the International Phonetic Alphabet.
According to this system, both cs in cepacia would be pro-
nounced hard (like English k); the first vowel, e, would be long
(approximately as in Received Pronunciation of gate); the sec-
ond, a, would also be long (approximately as in RP father); i
(as in dip) and a would be short; and the stress would fall on
the second syllable. There is some degree of artificiality in this
system, since cepacia is not a classical word but a later scien-
tific coinage, formed from the classical Latin caepa. Indeed,
this scholarly pronunciation does not correspond with any cur-
rent pronunciations in the scientific and infectious disease com-
munities. Any attempt to introduce it as a standard might para-
doxically cause further confusion. 
The standard pronunciation of Latin that scholars have
reconstructed implies the primacy (for literary purposes) of the
so-called Golden Age of Caesar, Cicero, and the Augustan
poets and historians. Infectious disease specialists in the 21st
century should not adopt this pronunciation, unless it is a gen-
uinely useful and acceptable solution to a real problem. Our
times, unlike the era of the Gileadites, do not deem mispronun-
ciation a capital offence. Classicists should be willing to help if
they are asked but have no proprietary rights over the function-
al idiolect of modern scientific Latin whose users can use what-
ever pronunciation they find conducive to communication.
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